The Brazilian lab group, Hermes Pardini, will sell 40.2m shares with an indicative pricing of BRL17.50 to BRL21.50. At the upper bound, the company is valued at BRL864.3m (US$274m).
The fate of French laboratory network Cerba is finally determined – as owners PAI Partners agree to sell the group to private equity firm Partners Group and pension fund PSP. So what will happen to Cerba now that it changes hands?
PAI Partners has sold French medical laboratory services operator Cerba HealthCare to Swiss private equity house Partners Group and Canadian pension fund PSP Investments for €1.8bn –before second round bids started in February. Healthcare Europa understands Partners Group acquired a majority stake and PSP Investments a significant minority stake in the group.
MedLife, the largest private healthcare operator in Romania, has purchased a majority stake (80%) in medical services company Almina SRL, which runs eight medical centres in the counties of Dambovita and Ilfovs.
Manasije Mishra is the CEO of Aetna India, and managing director of Indian Health Organisation (IHO). IHO runs a membership scheme which, for a modest fee, gives its half-a-million members access to everything from free consultations with a doctor to access to discounted outpatient and lab services, and telemedicine. We talk to him about his business model, his members, and his plans for expansion.
French laboratory chain Cerba could be valued at up to €2bn -with three bidders still in the race. It is rumoured the group could sell before February, when second round bids are set. But owner PAI Partners may not get the price it hoped for.
The High Court of Delhi has accepted an application by the Japanese drug maker Daiichi Sankyo to block the sale of the Indian hospital group Fortis Healthcare to the private equity house TPG today. The Singh brothers, who own 83% of the group, were reportedly considering an INR 3,000 crore (US$451m) bid for a 26% stake in the group with a “control premium”.
Medicover says it is not in negotiations to convert a shopping centre in the central Romanian city of Brasov into a private hospital - for now. But the group is keen to further expand in the country ahead of a potential IPO this year.
The Abraaj Group has partnered with Islamabad Diagnostics Centre, a leading diagnostics chain in Pakistan. But what is its plan for Pakistan - and beyond? Are they looking to IPO eventually, or build a network of integrated services? Healthcare Nova speaks to managing director Hisham Moussa.
The Abraaj Group, a private equity investor based in Dubai, and the owner of India’s CARE Hospitals, is close to a deal for the south Indian diagnostic group Medall according to reports in the local press.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
